Novo sues Hims, alleging patent infringement
Danish pharmaceutical giant said Monday it has sued , accusing it of infringing on one of its key patents for semaglutide, the active ingredient in Ozempic and Wegovy. Shares of Hims extended losses ...
Hims to stop offering copy of Wegovy pill following FDA scrutiny
said it has decided to stop offering its newly launched copycat version of Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. “Since launching the compoun...
FDA says it will take “decisive steps” against GLP-1 compounders, HHS refers Hims to DOJ for investigation
The Food and Drug Administration said it would take "decisive steps" to restrict GLP-1 compounding, a day after announced that it would sell copies ofWegovy pill.
Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy
CEO Mike Doustdar appeared to learn in real time on Thursday that — a thorn in Novo’s side for more than a year — planned to sell copies of his company’s new oral weight-loss drug . Hims announced it...
Novo and Lilly rise, Hims falls on FDA “illegal copycat drugs” warning
Investors are reacting premarket to US Food and Drug Administration Commissioner Marty Makary signaling a crackdown on unapproved drugs that are marketed as being similar to FDA-approved products. In ...
Hims to offer copies of Wegovy pill at $49 a month for starting dose, Novo threatens legal action
will offer copies of Wegovy pill at $49 for a starting dose, the company announced Thursday, a sign that the telehealth giant is doubling down on copycat versions of blockbuster weight-loss drugs ove...
Novo and Lilly agree prices are falling — and disagree on what comes next
The two drugmakers behind the weight-loss drug boom see the market heading in the same direction — but their own futures diverging sharply. and together sold nearly $70 billion worth of their blockbu...
Ozempic is no longer the most searched for GLP-1 in the US
Ozempic, the popular diabetes drug made by , used to be shorthand for an entire class of diabetes and weight-loss medications. Not anymore. According to Google Trends data, as of January, more people ...
Hims adds cancer detection test to Labs product
will add Galleri, a cancer detection test made by , to its offerings as it works to expand its Labs product. Hims said Wednesday that it would add the blood test, which says it detects signals for ove...
Eli Lilly crushes Q4 estimates, gives cheery 2026 guidance
reported earnings results on Wednesday that crushed Wall Street estimates, with upbeat full-year guidance the cherry on top. The stock jumped in the early reaction to the print, gaining as much as 9%....
Novo Nordisk’s slide continues after CEO warns of “unprecedented pricing pressure” as outlook overshadows Q4 results
shares are tumbling further in premarket trading on Wednesday after CEO Mike Doustdar warned that the Danish pharma giant will face “unprecedented” price pressures in 2026, addressing the company’s an...
Novo expects sales will drop in 2026 amid rising competition
Ozempic maker expects annual sales to decline by up to 13% in 2026 despite signs that its new Wegovy pill, the first oral GLP-1 to come to market, is having strong early uptake. The pharmaceutical gi...
Pfizer beats Q4 estimates, releases mid-stage GLP-1 trial results, and maintains guidance for full-year 2026
reported earnings that beat Wall Street estimates, reaffirmed its full-year guidance, and released mid-stage trial results for its upcoming weight-loss drug. Still, shares slipped as the company’s ful...
Merck reports better-than-expected Q4 results, but full-year guidance misses expectations
reported Q4 results that beat Wall Street estimates but gave full-year guidance below expectations. For the last three months of 2025, Merck reported: Adjusted earnings per share of $2.04, compared to...
How Novo Nordisk’s new Wegovy pill is transforming the weight-loss drug market
Less than a month after it came to market, Wegovy pill is already reshaping the obesity drug market. Since the drug launched on January 5, telehealth companies have reported strong demand from patien...
When is TrumpRx launching?
TrumpRx — the government’s drug pricing initiative, which is at the center of the tariff deals the administration has reached with drugmakers since September — is still not operational, and it’s uncle...
Americans can expect to live longer than ever, per the latest CDC data
Toward the end of last year, US entrepreneur, venture capitalist, and man who measures pretty much every aspect of his existence, Bryan Johnson, tweeted that he hopes to achieve immortality by 2039 . ...
Moderna extends rally on positive cancer vaccine results
has more than doubled since it announced on Tuesday that its cancer vaccine reduced the risk of relapse or death for melanoma patients. The five-year data from a Phase 2b trial showed that Moderna’s v...
J&J slips despite cheery 2026 guidance
reported fourth-quarter sales that beat expectations and gave rosy guidance for 2026. The company said it expects to bring in between $100 billion and $101 billion in revenue this year, compared to th...
Pharma largely unfazed as Greenland tariffs roil markets
President Trump’s threats to slap tariffs on European countries as the US intensifies efforts to acquire Greenland have put the US stock market into panic mode. Drugmakers, which are some of the most ...